Join Our Newsletter
|
Contact
|
Glossary
Facebook
Twitter
Linkedin
MENU
MENU
Latest
The Source Blog
Key Issues
Market Consolidation
Provider Contracts
Price Transparency
Pharmaceuticals
System Reform
COVID-19 Crisis
State Action
SLIHCQ Database
Overview
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
About
The Source Team
Source Sightings
Latest
The Source Blog
Key Issues
Market Consolidation
Provider Contracts
Price Transparency
Pharmaceuticals
System Reform
COVID-19 Crisis
State Action
Overview
SLIHCQ Database
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
About
The Source Team
Source Sightings
Search
Articles & Reports
Key Issues
All
HEALTHCARE MARKETS
- Provider Network
-- Telehealth or Telemedicine
-- Scope of Practice
-- Any Willing Provider
-- Network Adequacy
-- Tiered Network or Narrow Network
- Competition
-- Antitrust Enforcement
-- Healthcare Consolidation
-- Most Favored Nation (MFN)
-- Certificate of Need (CON)
-- Certificate of Public Advantage (COPA)
-- All-or-Nothing
-- Anti-Steering or Anti-Tiering
-- Non-Compete Provision
-- Price Manipulation
-- Competitive Bidding
-- Trade Secret
- Rate Regulation
- ACA Marketplace
HEALTHCARE COSTS
- Cost Containment
-- Shared Savings or Right to Shop
-- Reference Pricing
-- Prior Authorization
-- Utilization Review
- Price Gouging
- Cost-Sharing or Out-of-Pocket Costs
- High Deductible Health Plan (HDHP)
- Health Savings Account (HSA) or Health Reimbursement Account (HRA)
- Benefit Design
- Provider Payment
-- Value-Based Payment
-- Bundled Payment
-- Global Payment or Global Budget
-- Capitation
-- Population-Based Payment
-- Shared Risk or Risk-Based Payment
-- Facility Fee
HEALTHCARE SYSTEM REFORM
- COVID-19 Crisis
- Single Payer or Multi-Payer
- Public Option
- Delivery Reform
- Quality or Value-Based Reform
- Managed Competition
- Accountable Care Organization (ACO)
- Medicaid Reform or Medicaid Waiver
- Affordable Care Act (ACA)
- Federal Reform Effort
PRICE AND QUALITY TRANSPARENCY
- All-Payer Claims Database (APCD)
- Gag Clause or Non-Disclosure Agreement
- Surprise Billing or Balance Billing
- Quality Measure
PHARMACEUTICALS
- Drug Pricing
- Drug Formulary
- Pharmacy Benefit Manager (PBM)
- Pharmacy Regulation
-- Clawback Restriction
- Biosimilar or Generic Competition
-- Generic Competition Block or Delay
- Therapeutic Substitution
- Medicaid Pharmaceuticals
- Medicare Part D
- 340B Drug Pricing Program
- Drug Importation
Jurisdiction
All
Federal
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Start Date
End Date
Kaiser Family Foundation
Millions of Medicare Part D Enrollees Have Had Out-of-Pocket Drug Spending Above the Catastrophic Threshold Over Time
July 23, 2021
Center for American Progress
H.R. 3 Could Save Patients Thousands of Dollars on Prescription Drugs
July 20, 2021
Public Knowledge
A New Section 5 Policy Statement Can Help the FTC Defend Competition
July 20, 2021
32BJ Health Fund
Price Transparency Compliance Among NYC Hospitals
July 20, 2021
The Milbank Quarterly
Consolidation of Hospitals During the COVID-19 Pandemic: Government Bailouts and Private Equity
July 20, 2021
Patient Rights Advocate
Semi-Annual Hospital Price Transparency Compliance Report July 2021
July 19, 2021
The Commonwealth Fund
As the Pandemic Eases, What Is the State of Health Care Coverage and Affordability in the U.S.?
July 16, 2021
The Commonwealth Fund
More Is More: Expanding Access to Primary Care While Maintaining Quality
July 15, 2021
Journal of Health Politics, Policy and Law
Health Insurance Loss during COVID-19 Increases Support for Universal Health Coverage
July 15, 2021
Journal of Health Politics, Policy and Law
The No Surprises Act: A Bipartisan Achievement to Protect Consumers from Unexpected Medical Bills
July 15, 2021
NEJM
California v. Texas — Ending the Campaign to Undo the ACA in the Courts
July 14, 2021
Urban Institute
Filling the Medicaid Gap with a Public Option
July 14, 2021
The American Journal of Managed Care
Large Self-insured Employers Lack Power to Effectively Negotiate Hospital Prices
July 13, 2021
JAMA Network
The Growing Problem of Out-of-Pocket Costs and Affordability in Employer-Sponsored Insurance
July 9, 2021
JAMA Network
Drug Pricing Reform in 2021—Going Big or Going Bipartisan?
July 8, 2021
KaufmanHall
M&A Quarterly Activity Report: Q2 2021
July 8, 2021
Next
